drugset / Trial / NCT06130384
Pain Reduction With Topical Bromfenac Versus Artificial Tear After Intravitreal Injection.
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this prospective interventional study is to compare post-intravitreal injection pain between eyes receiving topical bromfenac versus artificial tears as an analgesic after intravitreal injection.
Timeline
- Start
- 2021-03-01
- Primary completion
- 2023-08-15
- Completion
- 2023-11-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bromfenac | Other / unclassified | 0.09 % | Topical |
Indications
No indication recorded.